Nocardiosis
Nocardiosis | |
---|---|
Other names: Lung nocardiosis[1] | |
| |
Specialty | Infectious disease |
Symptoms | Presentation depend on the site of infection[3] |
Complications | Brain abscess,meningitis,osteomyelitis[2] |
Causes | Nocardia asteroides or Nocardia brasiliensis[2] |
Risk factors | Alcoholism,chronic lung disease,solid-organ transplant,use of corticosteroids[2] |
Diagnostic method | Bacterial cultures[2] |
Differential diagnosis | Bacterial pneumonia,community-acquired pneumonia, Glioblastoma multiforme,Kaposi sarcoma[2] |
Treatment | Amikacin, imipenem, meropenem[2] |
Nocardiosis is an infectious disease affecting either the lungs (pulmonary nocardiosis) or the whole body (systemic nocardiosis). It is due to infection by a bacterium of the genus Nocardia, most commonly Nocardia asteroides or Nocardia brasiliensis.[2][4]
It is most common in adult males, especially those with a weakened immune system. In individuals with brain nocardia infection, mortality exceeds 80%; in other forms, mortality is 50%, even with appropriate therapy.[5] It is one of several conditions that have been called "the great imitator".[6] Cutaneous nocardiosis commonly occurs in immunocompetent hosts.[7]
Signs and symptoms
- Produces a virulent form of pneumonia (progressive)
- Night sweats, fever, cough, chest pain
- Pulmonary nocardiosis is subacute in onset and refractory to treatment with standard antibiotics
- Symptoms are more severe in immunocompromised individuals
- Radiologic studies show multiple pulmonary infiltrates
Neurological infection[11]
- Headache, lethargy, confusion, seizures, sudden onset of neurological deficit
- CT scan shows cerebral abscess
- Nocardial meningitis may be difficult to diagnose
- Nocardia has been highly linked to endocarditis as a main manifestation
- In recorded cases, it has caused damage to heart valves whether natural or prosthetic
Lymphocutaneous disease[14][15][16]
- Nocardial cellulitis is akin to erysipelas but is less acute
- Nodular lymphangeitis mimics sporotrichosis with multiple nodules alongside a lymphatic pathway
- Chronic subcutaneous infection is a rare complication
- Cultures must incubate more than 48 hours to guarantee an accurate test
Ocular disease[17]
- Very rarely, nocardiae cause keratitis
- Generally there is a history of ocular trauma
Disseminated nocardiosis[18][19][20]
- Dissemination occurs through the spreading enzymes possessed by the bacteria
- Disseminated infection can occur in very immunocompromised patients
- It generally involves both lungs and brain
- Fever, moderate or very high can be seen
- Multiple cavitating pulmonary infiltrates develop
- Cerebral abscesses arise later
Causes
Normally found in soil, these organisms cause occasional sporadic disease in humans and animals throughout the world. Another well publicized find is that of Nocardia as part of the oral microflora. Nocardia spp. have been reported in the normal gingivae and periodontal pockets along with other species such as Actinomyces, Arthromyces and Streptomyces spp.[21]
The usual mode of transmission is inhalation of organisms suspended in dust. Another very common method is by traumatic introduction, especially in the jaw. This leads to the entrance of Nocardia into the blood stream and the propagation of its pathogenic effects. Transmission by direct inoculation through puncture wounds or abrasions is less common.[5]
Generally, nocardial infection requires some degree of immune suppression.[4]
A weakened immune system is a general indicator of a person who is more susceptible to nocardiosis, such as someone who already has a disease that weakens their immune system. Additionally, those with low T-cell counts or other complications involving T-cells can expect to have a higher chance of becoming infected. Besides those with weak immune systems, a local traumatic inoculation can cause nocardiosis, specifically the cutaneous, lymphocutaneous, and subcutaneous forms of the disease.[22][23]
Risk factors
In terms of risk factors that are associated with Nocardiosis we find the following:[2]
- HIV
- Solid-organ transplant
- Hematological malignancy
- Alcoholism
- Whipple disease
Diagnosis
Diagnosis of nocardiosis can be made by a doctor using various techniques. These techniques include, but are not limited to: a chest x-ray to analyze the lungs, a bronchoscopy, a brain/lung/skin biopsy, or a sputum culture. [24]
However, diagnosis may be difficult. Nocardiae are gram positive, weakly acid-fast, branching rod-shaped bacteria and can be visualized by a modified Ziehl–Neelsen stain such as the Fite-Faraco method. In the clinical laboratory, routine cultures may be held for insufficient time to grow nocardiae, and referral to a reference laboratory may be needed for species identification.[24]
Pulmonary infiltration and pleural effusion are usually detected via x-ray.[25]
Differential diagnosis
In terms of the DDx we find the following should considered:[2]
Treatment
Nocardiosis requires at least 6 months of treatment, preferably with trimethoprim/sulfamethoxazole or high doses of sulfonamides. In patients who do not respond to sulfonamide treatment, other drugs may be added( ampicillin, erythromycin, or minocycline).[26][2][27][28]
Treatment also includes surgical drainage of abscesses and excision of necrotic tissue. The acute phase requires complete bed rest; as the patient improves, activity can increase.[5]
A new combination drug therapy (sulfonamide, ceftriaxone, and amikacin) has also shown promise.[24]
Prognosis
The prognosis of nocardiosis is highly variable. The state of the host's health, site, duration, and severity of the infection all play parts in determining the prognosis. Currently, skin and soft tissue infections have a 100% cure rate, and pleuropulmonary infections have a 90% cure rate with appropriate therapy. The cure rate falls to 63% with those infected with disseminated nocardiosis. Additionally, 23% of people who are infected in the central nervous system (CNS) die. There are no preventative treatments for nocardiosis. The only recommendation is to protect open wounds to limit entrance of the bacterium.[2][29][30]
Epidemiology
Although there are no international data available on worldwide infection rates per year, there are roughly 500–1000 documented cases of nocardiosis per year in the US. Most of these cases occur in men, as there is a 3:1 ratio of male to female cases annually; however, this difference may be due to exposure frequency rather than susceptibility differences. From an age perspective, it is not highly more prevalent in one age group than another.[22]
Cutaneous nocardiosis is slightly more common in middle aged men, but as a whole, all age groups are susceptible.[32]
A 2022 article by Wang, et al indicates the geographical locations and distribution of Nocardia spp. from individuals diagnosed with nocardiosis in 21 cities/provinces in China between the years 2009 and 2021 recovering 441 nocardiosis strains[31]
History
In terms of history we find that Nocardial infections were first explained by Edmond Nocard (1850-1903), who was a French veterinarian, as well as a microbiologist.[33]
References
- ↑ "Nocardiosis - Symptoms, Causes, Treatment | NORD". rarediseases.org. Archived from the original on 2023-03-28. Retrieved 2024-11-10.
- ↑ 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 2.11 Rawat, Deepa; Rajasurya, Venkat; Chakraborty, Rebanta K.; Sharma, Sandeep (2024). "Nocardiosis". StatPearls. StatPearls Publishing. PMID 30252331. Archived from the original on 2022-07-15. Retrieved 2024-11-07.
- ↑ "Orphanet: Nocardiosis". www.orpha.net. Retrieved 10 November 2024.
- ↑ 4.0 4.1 "About Nocardiosis". Nocardiosis. 9 June 2024. Archived from the original on 11 June 2024. Retrieved 14 November 2024.
- ↑ 5.0 5.1 5.2 "Nocardiosis: DBMD - WrongDiagnosis.com". web.archive.org. 26 September 2007. Archived from the original on 26 September 2007. Retrieved 24 November 2024.
{{cite web}}
: CS1 maint: bot: original URL status unknown (link) - ↑ Lederman ER, Crum NF (September 2004). "A case series and focused review of nocardiosis: clinical and microbiologic aspects". Medicine (Baltimore). 83 (5): 300–13. doi:10.1097/01.md.0000141100.30871.39. PMID 15342974. S2CID 23940448.
- ↑ Rapini, Ronald P.; Bolognia, Jean L.; Jorizzo, Joseph L. (2007). Dermatology: 2-Volume Set. St. Louis: Mosby. ISBN 978-1-4160-2999-1.
- ↑ Kandi, Venkataramana (15 August 2015). "Human Nocardia Infections: A Review of Pulmonary Nocardiosis". Cureus. 7 (8): e304. doi:10.7759/cureus.304. PMC 4571773. PMID 26430578.
- ↑ Zia, Khurram; Nafees, Taha; Faizan, Muhammad; Salam, Osama; Saad, Syeda Ifra; Khan, Yasir A; Altaf, Ahmed (26 May 2019). "Ten Year Review of Pulmonary Nocardiosis: A Series of 55 Cases". Cureus. 11 (5): e4759. doi:10.7759/cureus.4759. PMC 6663111. PMID 31363440.
- ↑ "Pulmonary nocardiosis: MedlinePlus Medical Encyclopedia". medlineplus.gov. Archived from the original on 10 November 2024. Retrieved 22 November 2024.
- ↑ Anagnostou, Theodora; Arvanitis, Marios; Kourkoumpetis, Themistoklis K.; Desalermos, Athanasios; Carneiro, Herman A.; Mylonakis, Eleftherios (January 2014). "Nocardiosis of the Central Nervous System: Experience From a General Hospital and Review of 84 Cases From the Literature". Medicine. 93 (1): 19–32. doi:10.1097/MD.0000000000000012. PMC 4616325. PMID 24378740.
- ↑ "Nocardia Endocarditis in a Native Mitral Valve Revista Espanola de Cardiologia Volume 57, Issue 8, August 2004, Pages 787–788". doi:10.1016/S1885-5857(06)60314-9. Archived from the original on 2018-06-14. Retrieved 2021-05-30.
- ↑ Daikos, G. L.; Syriopoulou, V.; Horianopoulou, M.; Kanellopoulou, M.; Martsoukou, M.; Papafrangas, E. (2003). "Successful Antimicrobial Chemotherapy for Nocardia Asteroides Prosthetic Valve Endocarditis The American Journal of Medicine, Volume 115, Issue 4, Pages 330–332". The American Journal of Medicine. 115 (4): 330–332. doi:10.1016/S0002-9343(03)00350-4. PMID 12967703. Archived from the original on 2018-06-20. Retrieved 2021-05-30.
- ↑ Bryant, Elizabeth; Davis, Carrie L.; Kucenic, Michael James; Mark, Lawrence A. (February 2010). "Lymphocutaneous nocardiosis: a case report and review of the literature". Cutis. 85 (2): 73–76. ISSN 0011-4162. PMID 20349680. Archived from the original on 2022-06-17. Retrieved 2024-11-20.
- ↑ "Dermatologic Manifestations of Nocardiosis: Background, Pathophysiology, Epidemiology". 2016-09-27. Archived from the original on 2021-04-20. Retrieved 2021-05-30.
{{cite journal}}
: Cite journal requires|journal=
(help) - ↑ "Clinical Overview of Nocardiosis". Nocardiosis. 5 June 2024. Archived from the original on 20 September 2024. Retrieved 23 November 2024.
- ↑ Castle, George; Heath, Gregory (17 May 2021). "Endogenous ocular nocardiosis". GMS Ophthalmology Cases; 11:Doc10. 11: Doc10. doi:10.3205/oc000183. PMC 8167374. PMID 34123700.
- ↑ Li, Ting; Chen, Yi-Xin; Lin, Jia-Jia; Lin, Wei-Xian; Zhang, Wei-Zhen; Dong, Hang-Ming; Cai, Shao-Xi; Meng, Ying (6 October 2022). "Successful treatment of disseminated nocardiosis diagnosed by metagenomic next-generation sequencing: A case report and review of literature". World Journal of Clinical Cases. 10 (28): 10120–10129. doi:10.12998/wjcc.v10.i28.10120. ISSN 2307-8960. PMC 9561593. PMID 36246801.
- ↑ Budzik, Jonathan M.; Hosseini, Mojgan; Mackinnon, Alexander C.; Taxy, Jerome B. (June 2012). "Disseminated Nocardia farcinica : Literature Review and Fatal Outcome in an Immunocompetent Patient". Surgical Infections. 13 (3): 163–170. doi:10.1089/sur.2011.012. ISSN 1096-2964. PMC 3375863. PMID 22612440.
- ↑ Yetmar, Zachary A; Khodadadi, Ryan B; Chesdachai, Supavit; McHugh, Jack W; Challener, Douglas W; Wengenack, Nancy L; Bosch, Wendelyn; Seville, Maria Teresa; Beam, Elena (1 August 2023). "Mortality After Nocardiosis: Risk Factors and Evaluation of Disseminated Infection". Open Forum Infectious Diseases. 10 (8): ofad409. doi:10.1093/ofid/ofad409. PMC 10422863. PMID 37577117.
- ↑ Roth, GD; Thurn, AN (Nov–Dec 1962). "Continued study of oral nocardia". Journal of Dental Research. 41 (6): 1279–92. CiteSeerX 10.1.1.523.2905. doi:10.1177/00220345620410060401. PMID 13975308. S2CID 26640128.
- ↑ 22.0 22.1 "Nocardiosis: Background, Pathophysiology, Epidemiology". 2016-07-25. Archived from the original on 2021-01-17. Retrieved 2021-05-30.
{{cite journal}}
: Cite journal requires|journal=
(help) - ↑ Wilson, John W. (2016-11-10). "Nocardiosis: Updates and Clinical Overview". Mayo Clinic Proceedings. 87 (4): 403–407. doi:10.1016/j.mayocp.2011.11.016. ISSN 0025-6196. PMC 3498414. PMID 22469352.
- ↑ 24.0 24.1 24.2 "Nocardiosis: DBMD—WrongDiagnosis.com". Archived from the original on 2007-09-26. Retrieved 2007-07-12.
- ↑ "Nocardiosis Workup: Laboratory Studies, Imaging Studies, Other Tests". emedicine.medscape.com. Retrieved 17 November 2024.
- ↑ Margalit, Ili; Lebeaux, David; Tishler, Ori; Goldberg, Elad; Bishara, Jihad; Yahav, Dafna; Coussement, Julien (April 2021). "How do I manage nocardiosis?". Clinical Microbiology and Infection. 27 (4): 550–558. doi:10.1016/j.cmi.2020.12.019. PMID 33418019.
- ↑ "Nocardiosis Treatment & Management: Medical Care, Surgical Care, Consultations". eMedicne. 29 October 2024. Archived from the original on 1 December 2023. Retrieved 22 November 2024.
- ↑ Root, Heather; Daniels, Lindsay; Marx, Ashley; Bartelt, Luther A.; Lachiewicz, Anne M.; van Duin, David (February 2021). "Sulfonamides without trimethoprim in the treatment of Nocardia infections: A case report and literature review". Transplant Infectious Disease: An Official Journal of the Transplantation Society. 23 (1): e13452. doi:10.1111/tid.13452. ISSN 1399-3062. PMID 32869901. Archived from the original on 2024-10-03. Retrieved 2024-11-22.
- ↑ "Nocardiosis: Background, Pathophysiology, Epidemiology". eMedicine. 29 October 2024. Retrieved 21 November 2024.
- ↑ Meena, Durga Shankar; Kumar, Deepak; Bohra, Gopal Krishana; Midha, Naresh; Garg, Mahendra Kumar (2022). "Clinical Characteristics and Treatment Outcome of Central Nervous System Nocardiosis: A Systematic Review of Reported Cases". Medical Principles and Practice. 31 (4): 333–341. doi:10.1159/000525509. PMC 9485982. PMID 35700710.
- ↑ 31.0 31.1 Wang, Hao; Zhu, Yue; Cui, Qiaozhen; Wu, Wenming; Li, Gang; Chen, Dongke; Xiang, Lili; Qu, Jiuxin; Shi, Dongyan; Lu, Binghuai (27 April 2022). "Epidemiology and Antimicrobial Resistance Profiles of the Nocardia Species in China, 2009 to 2021". Microbiology Spectrum. 10 (2): e01560-21. doi:10.1128/spectrum.01560-21. PMC 9045199. PMID 35234511.
- ↑ "Dermatologic Manifestations of Nocardiosis: Background, Pathophysiology, Epidemiology". 2016-09-27. Archived from the original on 2021-04-20. Retrieved 2021-05-30.
{{cite journal}}
: Cite journal requires|journal=
(help) - ↑ Duggal, Shalini Dewan; Chugh, Tulsi Das (2020). "Nocardiosis: A Neglected Disease". Medical Principles and Practice. 29 (6): 514–523. doi:10.1159/000508717. PMC 7768126. PMID 32422637.
External links
Webmd article on Nocardiosis Archived 2021-03-01 at the Wayback Machine
Classification | |
---|---|
External resources |